NCT00081601View on ClinicalTrials.gov

Study of CEP-701 in Treatment of Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

May 31, 2005

Study Completion Date

June 30, 2005

Conditions
Prostate Cancer
Interventions
DRUG

CEP-701

Trial Locations (1)

21287

Johns Hopkins, Baltimore

Sponsors

Lead Sponsor

Cephalon
All Listed Sponsors
lead

Cephalon

INDUSTRY

NCT00081601 - Study of CEP-701 in Treatment of Prostate Cancer | Biotech Hunter | Biotech Hunter